Neo Two-cancer Screening Benefits Both Nation and the People—A Response to Fight for Men’s Health: Call of Bladder Cancer and Prostate Cancer Screening

Pingping Zhu^*

Show Less

¹ School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China

CP 2021, 3(1), 40–41;

Submitted: 25 November 2020 | Accepted: 7 January 2021 | Published: 3 February 2021

© 2021 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Antoni S, Ferlay J, Soerjomataram I, et al., 2017, Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur Urol, 71:96–108. DOI: 10.1016/j.eururo.2016.06.010.

Cooperberg MR, Carroll PR, 2015, Trends in Management for Patients With Localized Prostate Cancer, 1990-2013. JAMA, 314:80–2. DOI: 10.1001/jama.2015.6036.

Collins FS, Varmus H, 2015, A New Initiative on Precision Medicine. N Engl J Med, 372:793–5.

Chou R, Gore JL, Buckley D, et al., 2015, Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis. Ann Internal Med, 163:922–31. DOI: 10.7326/m15-0997.

Llop E, Ferrer-Batalle M, Barrabes S, et al., 2016, Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-specific Changes. Theranostics, 6:1190–204. DOI: 10.7150/thno.15226.

Li C, Du Y, Yang Z, et al., 2016, GALNT1-mediated Glycosylation and Activation of Sonic Hedgehog Signaling Maintains the Self-renewal and Tumor-initiating Capacity of Bladder Cancer Stem Cells. Cancer Res, 76:1273–83. DOI: 10.1158/0008-5472.can-15-2309.

Li C, Yan RP, Yang Z, et al., 2017, BCMab1-Ra, a Novel Immunotoxin that BCMab1 Antibody Coupled to Ricin a Chain, Can Eliminate Bladder Tumor. Oncotarget, 8:46704–5. DOI: 10.18632/oncotarget.13504.

Li C, Yang Z, Du Y, et al., 2014, BCMab1, a Monoclonal Antibody Against Aberrantly Glycosylated Integrin Alpha3beta1, has Potent Antitumor Activity of Bladder Cancer in vivo. Clin Cancer Res, 20:4001–13. DOI: 10.1158/1078-0432.ccr-13-3397.

Schmitz-Drager BJ, Droller M, Lokeshwar VB, et al., 2015, Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus. Urol Int, 94:1–24. DOI: 10.1159/000369357.

Shariat SF, Casella R, Khoddami SM, et al., 2004, Urine Detection of Survivin is a Sensitive Marker for the Noninvasive Diagnosis of Bladder Cancer. J Urol, 171:626–30. DOI: 10.1097/01.ju.0000107826.78479.90.

Jup C, Liang QL, Luo GA, et al., 2008, Determination of Ddehydroepiandrosterone in Emasculated Rat’s Serum by Gas Chromatography-tandem Mass Spectrometry. Chin J Anal Chem, 36:172–6.

Previous article in this issue

Next article in this issue

Cancer Plus, Electronic ISSN: 2661-3840 Print ISSN: 2661-3832, Published by AccScience Publishing